Central Nervous System Biomarkers Market, Global Outlook and Forecast 2023-2028

Report ID: 1632851 | Published Date: Jan 2025 | No. of Page: 63 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Central Nervous System Biomarkers Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Central Nervous System Biomarkers Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Central Nervous System Biomarkers Overall Market Size
    2.1 Global Central Nervous System Biomarkers Market Size: 2021 VS 2028
    2.2 Global Central Nervous System Biomarkers Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Central Nervous System Biomarkers Players in Global Market
    3.2 Top Global Central Nervous System Biomarkers Companies Ranked by Revenue
    3.3 Global Central Nervous System Biomarkers Revenue by Companies
    3.4 Top 3 and Top 5 Central Nervous System Biomarkers Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Central Nervous System Biomarkers Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Central Nervous System Biomarkers Players in Global Market
        3.6.1 List of Global Tier 1 Central Nervous System Biomarkers Companies
        3.6.2 List of Global Tier 2 and Tier 3 Central Nervous System Biomarkers Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Central Nervous System Biomarkers Market Size Markets, 2021 & 2028
        4.1.2 Safety Biomarker
        4.1.3 Efficacy Biomarker
        4.1.4 Validation Biomarker
        4.1.5 Other
    4.2 By Type - Global Central Nervous System Biomarkers Revenue & Forecasts
        4.2.1 By Type - Global Central Nervous System Biomarkers Revenue, 2017-2022
        4.2.2 By Type - Global Central Nervous System Biomarkers Revenue, 2023-2028
        4.2.3 By Type - Global Central Nervous System Biomarkers Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Central Nervous System Biomarkers Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Central Nervous System Biomarkers Revenue & Forecasts
        5.2.1 By Application - Global Central Nervous System Biomarkers Revenue, 2017-2022
        5.2.2 By Application - Global Central Nervous System Biomarkers Revenue, 2023-2028
        5.2.3 By Application - Global Central Nervous System Biomarkers Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Central Nervous System Biomarkers Market Size, 2021 & 2028
    6.2 By Region - Global Central Nervous System Biomarkers Revenue & Forecasts
        6.2.1 By Region - Global Central Nervous System Biomarkers Revenue, 2017-2022
        6.2.2 By Region - Global Central Nervous System Biomarkers Revenue, 2023-2028
        6.2.3 By Region - Global Central Nervous System Biomarkers Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Central Nervous System Biomarkers Revenue, 2017-2028
        6.3.2 US Central Nervous System Biomarkers Market Size, 2017-2028
        6.3.3 Canada Central Nervous System Biomarkers Market Size, 2017-2028
        6.3.4 Mexico Central Nervous System Biomarkers Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Central Nervous System Biomarkers Revenue, 2017-2028
        6.4.2 Germany Central Nervous System Biomarkers Market Size, 2017-2028
        6.4.3 France Central Nervous System Biomarkers Market Size, 2017-2028
        6.4.4 U.K. Central Nervous System Biomarkers Market Size, 2017-2028
        6.4.5 Italy Central Nervous System Biomarkers Market Size, 2017-2028
        6.4.6 Russia Central Nervous System Biomarkers Market Size, 2017-2028
        6.4.7 Nordic Countries Central Nervous System Biomarkers Market Size, 2017-2028
        6.4.8 Benelux Central Nervous System Biomarkers Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Central Nervous System Biomarkers Revenue, 2017-2028
        6.5.2 China Central Nervous System Biomarkers Market Size, 2017-2028
        6.5.3 Japan Central Nervous System Biomarkers Market Size, 2017-2028
        6.5.4 South Korea Central Nervous System Biomarkers Market Size, 2017-2028
        6.5.5 Southeast Asia Central Nervous System Biomarkers Market Size, 2017-2028
        6.5.6 India Central Nervous System Biomarkers Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Central Nervous System Biomarkers Revenue, 2017-2028
        6.6.2 Brazil Central Nervous System Biomarkers Market Size, 2017-2028
        6.6.3 Argentina Central Nervous System Biomarkers Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Central Nervous System Biomarkers Revenue, 2017-2028
        6.7.2 Turkey Central Nervous System Biomarkers Market Size, 2017-2028
        6.7.3 Israel Central Nervous System Biomarkers Market Size, 2017-2028
        6.7.4 Saudi Arabia Central Nervous System Biomarkers Market Size, 2017-2028
        6.7.5 UAE Central Nervous System Biomarkers Market Size, 2017-2028
7 Players Profiles
    7.1 Merck
        7.1.1 Merck Corporate Summary
        7.1.2 Merck Business Overview
        7.1.3 Merck Central Nervous System Biomarkers Major Product Offerings
        7.1.4 Merck Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
        7.1.5 Merck Key News
    7.2 Takeda Pharmaceutical
        7.2.1 Takeda Pharmaceutical Corporate Summary
        7.2.2 Takeda Pharmaceutical Business Overview
        7.2.3 Takeda Pharmaceutical Central Nervous System Biomarkers Major Product Offerings
        7.2.4 Takeda Pharmaceutical Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
        7.2.5 Takeda Pharmaceutical Key News
    7.3 Thermo Fisher Scientific
        7.3.1 Thermo Fisher Scientific Corporate Summary
        7.3.2 Thermo Fisher Scientific Business Overview
        7.3.3 Thermo Fisher Scientific Central Nervous System Biomarkers Major Product Offerings
        7.3.4 Thermo Fisher Scientific Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
        7.3.5 Thermo Fisher Scientific Key News
    7.4 Avacta Group
        7.4.1 Avacta Group Corporate Summary
        7.4.2 Avacta Group Business Overview
        7.4.3 Avacta Group Central Nervous System Biomarkers Major Product Offerings
        7.4.4 Avacta Group Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
        7.4.5 Avacta Group Key News
    7.5 Diagenic Asa
        7.5.1 Diagenic Asa Corporate Summary
        7.5.2 Diagenic Asa Business Overview
        7.5.3 Diagenic Asa Central Nervous System Biomarkers Major Product Offerings
        7.5.4 Diagenic Asa Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
        7.5.5 Diagenic Asa Key News
    7.6 Banyan Biomarkers
        7.6.1 Banyan Biomarkers Corporate Summary
        7.6.2 Banyan Biomarkers Business Overview
        7.6.3 Banyan Biomarkers Central Nervous System Biomarkers Major Product Offerings
        7.6.4 Banyan Biomarkers Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
        7.6.5 Banyan Biomarkers Key News
    7.7 Eli Lilly
        7.7.1 Eli Lilly Corporate Summary
        7.7.2 Eli Lilly Business Overview
        7.7.3 Eli Lilly Central Nervous System Biomarkers Major Product Offerings
        7.7.4 Eli Lilly Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
        7.7.5 Eli Lilly Key News
    7.8 Pfizer
        7.8.1 Pfizer Corporate Summary
        7.8.2 Pfizer Business Overview
        7.8.3 Pfizer Central Nervous System Biomarkers Major Product Offerings
        7.8.4 Pfizer Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
        7.8.5 Pfizer Key News
    7.9 Alseres Pharmaceuticals
        7.9.1 Alseres Pharmaceuticals Corporate Summary
        7.9.2 Alseres Pharmaceuticals Business Overview
        7.9.3 Alseres Pharmaceuticals Central Nervous System Biomarkers Major Product Offerings
        7.9.4 Alseres Pharmaceuticals Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
        7.9.5 Alseres Pharmaceuticals Key News
    7.10 Acumen pharmaceuticals
        7.10.1 Acumen pharmaceuticals Corporate Summary
        7.10.2 Acumen pharmaceuticals Business Overview
        7.10.3 Acumen pharmaceuticals Central Nervous System Biomarkers Major Product Offerings
        7.10.4 Acumen pharmaceuticals Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
        7.10.5 Acumen pharmaceuticals Key News
    7.11 EKF Diagnostics
        7.11.1 EKF Diagnostics Corporate Summary
        7.11.2 EKF Diagnostics Business Overview
        7.11.3 EKF Diagnostics Central Nervous System Biomarkers Major Product Offerings
        7.11.4 EKF Diagnostics Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
        7.11.5 EKF Diagnostics Key News
    7.12 Abiant
        7.12.1 Abiant Corporate Summary
        7.12.2 Abiant Business Overview
        7.12.3 Abiant Central Nervous System Biomarkers Major Product Offerings
        7.12.4 Abiant Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
        7.12.5 Abiant Key News
    7.13 Myriad RBM
        7.13.1 Myriad RBM Corporate Summary
        7.13.2 Myriad RBM Business Overview
        7.13.3 Myriad RBM Central Nervous System Biomarkers Major Product Offerings
        7.13.4 Myriad RBM Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
        7.13.5 Myriad RBM Key News
    7.14 Aposense
        7.14.1 Aposense Corporate Summary
        7.14.2 Aposense Business Overview
        7.14.3 Aposense Central Nervous System Biomarkers Major Product Offerings
        7.14.4 Aposense Central Nervous System Biomarkers Revenue in Global Market (2017-2022)
        7.14.5 Aposense Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Central Nervous System Biomarkers Market Opportunities & Trends in Global Market
    Table 2. Central Nervous System Biomarkers Market Drivers in Global Market
    Table 3. Central Nervous System Biomarkers Market Restraints in Global Market
    Table 4. Key Players of Central Nervous System Biomarkers in Global Market
    Table 5. Top Central Nervous System Biomarkers Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Central Nervous System Biomarkers Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Central Nervous System Biomarkers Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Central Nervous System Biomarkers Product Type
    Table 9. List of Global Tier 1 Central Nervous System Biomarkers Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Central Nervous System Biomarkers Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Central Nervous System Biomarkers Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Central Nervous System Biomarkers Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Central Nervous System Biomarkers Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Central Nervous System Biomarkers Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Central Nervous System Biomarkers Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Central Nervous System Biomarkers Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Central Nervous System Biomarkers Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Central Nervous System Biomarkers Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Central Nervous System Biomarkers Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Central Nervous System Biomarkers Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Central Nervous System Biomarkers Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Central Nervous System Biomarkers Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Central Nervous System Biomarkers Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Central Nervous System Biomarkers Revenue, (US$, Mn), 2023-2028
    Table 30. Merck Corporate Summary
    Table 31. Merck Central Nervous System Biomarkers Product Offerings
    Table 32. Merck Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
    Table 33. Takeda Pharmaceutical Corporate Summary
    Table 34. Takeda Pharmaceutical Central Nervous System Biomarkers Product Offerings
    Table 35. Takeda Pharmaceutical Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
    Table 36. Thermo Fisher Scientific Corporate Summary
    Table 37. Thermo Fisher Scientific Central Nervous System Biomarkers Product Offerings
    Table 38. Thermo Fisher Scientific Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
    Table 39. Avacta Group Corporate Summary
    Table 40. Avacta Group Central Nervous System Biomarkers Product Offerings
    Table 41. Avacta Group Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
    Table 42. Diagenic Asa Corporate Summary
    Table 43. Diagenic Asa Central Nervous System Biomarkers Product Offerings
    Table 44. Diagenic Asa Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
    Table 45. Banyan Biomarkers Corporate Summary
    Table 46. Banyan Biomarkers Central Nervous System Biomarkers Product Offerings
    Table 47. Banyan Biomarkers Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
    Table 48. Eli Lilly Corporate Summary
    Table 49. Eli Lilly Central Nervous System Biomarkers Product Offerings
    Table 50. Eli Lilly Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
    Table 51. Pfizer Corporate Summary
    Table 52. Pfizer Central Nervous System Biomarkers Product Offerings
    Table 53. Pfizer Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
    Table 54. Alseres Pharmaceuticals Corporate Summary
    Table 55. Alseres Pharmaceuticals Central Nervous System Biomarkers Product Offerings
    Table 56. Alseres Pharmaceuticals Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
    Table 57. Acumen pharmaceuticals Corporate Summary
    Table 58. Acumen pharmaceuticals Central Nervous System Biomarkers Product Offerings
    Table 59. Acumen pharmaceuticals Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
    Table 60. EKF Diagnostics Corporate Summary
    Table 61. EKF Diagnostics Central Nervous System Biomarkers Product Offerings
    Table 62. EKF Diagnostics Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
    Table 63. Abiant Corporate Summary
    Table 64. Abiant Central Nervous System Biomarkers Product Offerings
    Table 65. Abiant Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
    Table 66. Myriad RBM Corporate Summary
    Table 67. Myriad RBM Central Nervous System Biomarkers Product Offerings
    Table 68. Myriad RBM Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
    Table 69. Aposense Corporate Summary
    Table 70. Aposense Central Nervous System Biomarkers Product Offerings
    Table 71. Aposense Central Nervous System Biomarkers Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Central Nervous System Biomarkers Segment by Type in 2021
    Figure 2. Central Nervous System Biomarkers Segment by Application in 2021
    Figure 3. Global Central Nervous System Biomarkers Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Central Nervous System Biomarkers Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Central Nervous System Biomarkers Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Central Nervous System Biomarkers Revenue in 2021
    Figure 8. By Type - Global Central Nervous System Biomarkers Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Central Nervous System Biomarkers Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Central Nervous System Biomarkers Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Central Nervous System Biomarkers Revenue Market Share, 2017-2028
    Figure 12. US Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Central Nervous System Biomarkers Revenue Market Share, 2017-2028
    Figure 16. Germany Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 17. France Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Central Nervous System Biomarkers Revenue Market Share, 2017-2028
    Figure 24. China Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 28. India Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Central Nervous System Biomarkers Revenue Market Share, 2017-2028
    Figure 30. Brazil Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Central Nervous System Biomarkers Revenue Market Share, 2017-2028
    Figure 33. Turkey Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Central Nervous System Biomarkers Revenue, (US$, Mn), 2017-2028
    Figure 37. Merck Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Takeda Pharmaceutical Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Thermo Fisher Scientific Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Avacta Group Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Diagenic Asa Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Banyan Biomarkers Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Eli Lilly Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Pfizer Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Alseres Pharmaceuticals Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Acumen pharmaceuticals Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. EKF Diagnostics Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Abiant Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Myriad RBM Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Aposense Central Nervous System Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
63
Frequently Asked Questions
Central Nervous System Biomarkers Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Central Nervous System Biomarkers Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Central Nervous System Biomarkers Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports